CVE-2023-53734: Mayurik Dawa-Pharma

High severity, CVSS 8.7. EPSS: 0.5% chance of exploitation in the next 30 days.

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Affected products

• Mayurik Dawa-Pharma: version 1.0-2022 only

Published 2025-12-04. Last modified 2026-06-17.